Publications by authors named "M Jankovic Makek"

Background: Anecdotal information suggests that clinical practice regarding the use of putative hepatoprotective agents in TB treatment varies across countries in the WHO European Region.

Methods: Between November 2023 and May 2024, we conducted a standardised questionnaire survey on the use of putative hepatoprotective agents in patients receiving TB treatment among Tuberculosis Network European Trials Group (TBnet) representatives in countries in the WHO European Region.

Results: We received valid responses from 37 of 53 countries (69.

View Article and Find Full Text PDF

PHENIX presents a simultaneous measurement of the production of direct γ and π^{0} in d+Au collisions at sqrt[s_{NN}]=200  GeV over a p_{T} range of 7.5 to 18  GeV/c for different event samples selected by event activity, i.e.

View Article and Find Full Text PDF

BACKGROUNDTreatment outcomes and long-term survival of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in a real-world setting are difficult to assess, especially for species other than complex (MAC).METHODSThis was a retrospective cohort study on all Croatian residents with respiratory NTM isolates from 2006 to 2015, with follow-up to 2020.RESULTSTherapy was started in 98/137 (71.

View Article and Find Full Text PDF

Background: This study aimed to identify factors that influence the mortality rate of patients with coronavirus disease (COVID-19)-associated pulmonary aspergillosis (CAPA).

Methods: In this cross-sectional study, data from 23 centers across 15 countries, spanning the period of March 2020 to December 2021, were retrospectively collected. The study population comprised patients who developed invasive pulmonary aspergillosis while being treated for COVID-19 in the intensive care unit.

View Article and Find Full Text PDF
Article Synopsis
  • A study analyzed the management and mortality outcomes of nontuberculous mycobacterial (NTM) infections in solid organ transplant (SOT) recipients, focusing on data from 2008 to 2018.
  • Out of 85 patients with NTM infections and 169 matched controls, one-year mortality was significantly higher in the infected group (20%) compared to controls (3%), particularly among those who had lung transplants.
  • Factors like time to treatment and changes in immunosuppression levels did not show a direct correlation with mortality rates among the patients.
View Article and Find Full Text PDF